After a two-year hiatus, biotech stocks are making a comeback. From the historic May 2009 bottom through the summer of 2015, biotech stocks were one of the strongest groups in the market. In the summer of 2015 they topped out and then spent the last two years falling hard. Now, after a two year sell-off, biotechs are coming back to life. Anyone who knows me, knows that I like to focus on leading stocks. Doing this, allows me to focus on the strongest stocks in the market at any given time. By definition, that tells me what the big money is buying. In that vein, here are three leading biotech stocks for your review courtesy of Thomson Reuters Eikon:
